AlphAIalphai — Financial news for AI agents
fool.comAUG 126 min read$INUV

Inuvo (INUV) Q2 2026 Earnings Call Transcript

Inuvo (INUV) reported Q2 2026 revenue of $7.5 million, down 67% year over year, with legacy search revenue falling 80% to $3.9 million. Audience modeling revenue rose 19% to $3.6 million. Gross margin was 44%. Net loss was $4.0 million ($0.27/share). The company said it raised $13 million to retire debt and fund IntentKey AI, and launched healthcare and recruitment pilots.

Original reporting
fool.com
Published Aug 12, 2026, 2:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 3:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Inuvo (INUV) Q2 2026 Earnings Call Transcript — source image
Source · fool.com
Decision brief

The 30-second read

$INUVNeutralMed
01

Why it matters

Traders can update expectations for near-term profitability and balance-sheet risk based on the disclosed revenue mix, gross margin contraction, net loss/Adjusted EBITDA loss, and the $13M capital raise used for debt retirement and working capital.

02

Market read

A company-specific earnings call with concrete financials and balance-sheet actions, plus forward-looking product integration and vertical expansion plans.

03

What to watch

Ranger asset sale is small ($450k) and severance/rightsizing ($470k) may mask underlying demand weakness; conversion timelines for pilots into recurring revenue are not quantified.

Relevance 8/10Novelty 8/10Timing: after-hours earnings call, ahead of 10-Q filing this evening

Background

Inuvo’s Q2 2026 call frames results around a transition from legacy open-web search to IntentKey context-based audience modeling, amid industry disruption.

Company-level read

Ticker impact

$INUVNeutralMedium confidence
Context

Inuvo reported Q2 2026 revenue of $7.5M (down 67% YoY), plus $13M financing to retire debt and fund IntentKey AI.

Expected impact

Near-term volatility likely, with downside risk if legacy revenue decline persists and upside if audience-modeling pilots convert.

Evidence & confidence

The article provides multiple primary datapoints: revenue mix deterioration, gross margin compression, net loss/EBITDA loss, and specific financing and debt retirement actions that can re-rate balance-sheet risk.

Market effects

Sector

Highlights the ad-tech shift from identity-based tracking to context-based intent signals, reinforcing a competitive narrative for AI-native marketing measurement.

Regional

No clear regional-specific impact beyond US healthcare and recruitment vertical targeting.

Global

Primarily US-focused verticals (healthcare open enrollment, recruitment), with limited explicit global expansion detail.

Counterpoint

What could challenge this read

The $13M financing and debt retirement may reduce near-term liquidity risk, but the core operating trend still shows steep legacy-search revenue collapse and margin compression.

Key entities

  • company
    Inuvo Inc.

    Reported Q2 2026 financial results and discussed IntentKey AI technology expansion, financing, and operating restructuring.

  • executive
    Rob Buchner

    CEO who commented on open-web search model fracturing and discussed IntentKey integration into AI-native workflows.

  • executive
    Wallace D. Ruiz

    CFO who presented the quarter’s financial metrics and capital/debt actions.

  • technology
    IntentKey

    Patented AI technology described as identifying engagement without personal IDs or historical click streams.

  • technology
    MCP (Model Context Protocol)

    Server architecture discussed for integrating IntentKey intelligence into AI-native workflows like Claude and ChatGPT.

Read at source← All news

Related articles

AUG 11
$INUVMed

Inuvo, Inc. (INUV): Results of Operations and Financial Condition

Inuvo, Inc. (INUV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 4 inuvo_ex991.htm PRESS RELEASE inuvo_ex991.htm EXHIBIT 99.1 Inuvo Reports Second Quarter 2026 Results Audience Modeling Revenue Grows 19% as Company Streamlines Legacy Search and Strengthens Capital Position Management to host conference call at 4:15 PM ET, Tuesday, Augu

SEC EDGAR 8-K6 min
AUG 12
$AGLMed

Why is AGL Energy stock surging today?

AGL Energy shares rose 5.4% to A$8.6 after the company reported FY26 results. Underlying EBITDA increased 2% to A$2.10 billion, operating free cash flow rose 60% to A$850 million, and profit after tax was A$756 million. It declared a fully franked final dividend of 26 cents, taking FY26 total to 50 cents, and guided FY27 payout ratio of 55–60%.

investing.com3 min
AUG 12
$IMSRMed

Terrestrial Energy (IMSR) Q2 2026 Earnings Call Transcript

Terrestrial Energy (IMSR) held its Q2 2026 earnings call, reporting $283.4 million cash and investments as of June 30, 2026, and quarterly cash burn of $6.4 million. The company estimated $2.7 billion lifetime revenue per IMSR plant, with blended gross margin of 33%. Net loss was $9.4 million. It cited NRC licensing progress and a Texas A&M RELLIS site lease.

fool.com6 min
AUG 12
$ACNTMedAI 8/10

Ascent Industries (ACNT) Q2 2026 Earnings Call Transcript

Ascent Industries (ACNT) reported Q2 2026 net sales of $25.7 million, up 37.6% year over year, and adjusted EBITDA of $1.5 million versus a prior-year loss. Volume rose 15.2% and average selling prices rose about 23%. Liquidity was $46 million. The Midwest Graphic Sales acquisition added $1.9 million in sales and $300,000 adjusted EBITDA.

fool.com10 min
AUG 12
$PGENMed

Precigen (PGEN) Q2 2026 Earnings Call Transcript

Precigen (PGEN) reported Q2 2026 PAPZIMEOS net revenue of $53.1 million, up 145.8% sequentially from $21.6 million, and first quarterly net income of $20.1 million, or $0.05 per diluted share. Gross margin was 95% but management expects normalization to high 80% to low 90%. Cash and investments were $38.7 million at June 30, 2026.

fool.com6 min
AUG 12
$LEGNMedAI 8/10

Legend Biotech (LEGN) Q2 2026 Earnings Call Transcript

Legend Biotech (LEGN) reported Q2 2026 results on an earnings call. Worldwide CARVYKTI net trade sales were $657 million, up 50% YoY. Total revenue was $387.5 million, up 52% YoY, with adjusted net income of $63.1 million ($0.16/share). Cash was $965 million. Q3 gross margin guidance was in the lower 50% range.

fool.com7 min